Fraunhofer Institute for Production Technology IPT
The "Advanced Therapies" congress in London from 19 to 20 March 2024 will showcase the entire value chain of cell and gene therapy development: future-oriented pharmaceutical and biotech companies as well as research institutions and regulatory authorities will come together.
Leading the way for “Next Generation Production”, the Fraunhofer IPT will be presenting the Lab Automation Demonstrator for novel gene and cell products for the first time at Stand 25.
The model's system is based on a magnetic planar drive and can smoothly transport cell vessels from station to station – making it easy to automate liquid handling processes or carry out inline quality controls.
Together with the innovative "COPE" control software, flexible, free-chain processes can be implemented and fully bio-adaptive production in pharmaceutical and medical technology can be realized.
Contact Kai Janning, Head of the business unit "Life sciences engineering"
Find out more about lab automation here:
https://www.ipt.fraunhofer.de/en/offer/special-machines/laboratory-automation.html
Presenting at the congress are:
Julius Mathews, Research Associate Adaptive Production Control
Lecture "Digital-Twin-driven Process Control and Automation for resource-efficient Development of mRNA-based Vaccines and Therapies "
19 March, Track Viral Vector Manufacturing track, 3:50 p.m.
Louisa Weltin, Research Associate Automation in the Life Sciences, presentation: "Fully automated cell expansion for the production of three-dimensional functional implants"
20 March, Track Cell Therapy Manufacturing, 11:20 a.m.